Dracen Pharmaceuticals announces publication in Molecular Cancer Therapeutics

San Diego, CA (PRWEB) October 10, 2022 -- Dracen Pharmaceuticals Inc., a clinical stage biotech company developing anti-cancer drugs that target

Related Keywords

San Diego ,California ,United States ,Prague ,Praha ,Hlavníesto ,Czech Republic ,Robert Wild ,Institute Of Organic Chemistry ,Osage University Partners ,Biotech Fund ,Dracen Pharmaceuticals ,Dracen Pharmaceuticals Inc ,Pharmaceuticals Inc ,Molecular Cancer Therapeutics ,Induces Anti Tumor Efficacy Through Direct ,Broad Antagonism ,Glutamine Metabolism ,Adaptive Immune ,Deerfield Management ,Norganic Chemistry ,Press Release ,